Dialysis News and Research

Latest Dialysis News and Research

Study reveals high rate of atrial fibrillation in patients with early stages of CKD

Millions of Americans in the early stages of chronic kidney disease (CKD) are at an increased risk of having atrial fibrillation (AF) - a major risk factor for stroke - according to new research by investigators at Wake Forest University Baptist Medical Center.

29 Jul 2010

AMAG attributes increased second-quarter revenues of $18.8 million to Feraheme

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.

29 Jul 2010

DaVita releases second annual corporate social responsibility report

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today released its second annual corporate social responsibility (CSR) report, which highlights the company's philanthropic, sustainability and community-building efforts through 2009.

28 Jul 2010

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck announced a non-exclusive license agreement with Laboratory Corporation of America Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy.

28 Jul 2010

Genzyme accepts CMS decision for delaying Renvela administration to dialysis patients

Genzyme Corp.today said it welcomed the Centers for Medicare and Medicaid Services' decision not to include oral medications without IV equivalents in Medicare's End Stage Renal Disease patient benefit. According to the final rule, these medications, including Genzyme's Renvela (sevelamer carbonate), will not be included in the bundle until January 1, 2014.

28 Jul 2010

Medicare to bundle payments for end-stage renal care, reward quality

Medicare payment for end-stage renal disease care may soon be tied to performance and quality measures if a new proposed rule issued by the Centers for Medicare and Medicaid Services is finalized. "If the rule is finalized, ESRD providers that do not meet set standards" - two measures for anemia management and one for hemodialysis quality - "could have their Medicare payments lowered by up to 2 percent starting January 2012, the CMS said" (McKinney, 7/26).

28 Jul 2010

Fresenius Medical Care, Nikkiso enter 10-year exclusive distribution agreement for dialysis products in Japan

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, has entered into a long-term, 10-year exclusive distribution agreement with Japanese-based Nikkiso Co. Ltd. for hemodialysis and peritoneal dialysis products in Japan.

23 Jul 2010

NxStage Medical second-quarter net revenue increases 21% to $44.0 million

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record financial results for the second quarter of 2010 ended June 30, 2010, with total revenue above the top end of its guidance range.

23 Jul 2010

African Americans at increased risk of kidney failure caused by hypertension

Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.

23 Jul 2010

Discontinuing epoetin can normalize hemoglobin levels in hemodialysis patients

Discontinuing the anemia drug epoetin may be more effective than reducing the dose for normalizing potentially dangerous high hemoglobin levels in hemodialysis patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results provide useful information about the balance required between administering epoetin and achieving target hemoglobin levels.

23 Jul 2010

Baxter second-quarter global sales increase 2% to $3.2 billion

Baxter International Inc. today announced its financial results for the second quarter of 2010, reporting earnings in line with the company's previously issued guidance of $0.90 to $0.93 per diluted share.

From Baxter International Inc. 22 Jul 2010

World-first dialysis study set to reduce health costs

The results of a world-first controlled trial of dialysis start-time in patients with Stage V chronic kidney disease is set to have major impact on the cost and infrastructure of chronic kidney disease (CKD) treatment and dialysis services.

20 Jul 2010

Cardiac Science issues update on AED recall announced in November 2009

Cardiac Science Corporation has issued an update to customers affected by a recall first announced by the Company on November 13, 2009.

20 Jul 2010

Cardiac Science addresses outstanding issues relating to corrective AED field action with FDA

Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, announced it has addressed outstanding issues with the Food and Drug Administration relating to the corrective AED field action announced on November 13, 2009.

20 Jul 2010

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Here are highlights from the July issue of Mayo Clinic Women's HealthSource. You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required.

20 Jul 2010

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Kidney disease is a growing public health problem, with approximately half a million individuals in the United States requiring dialysis treatments to replace the function of their failed kidneys. The problem is particularly acute among African-Americans, whose rates of kidney disease are four times higher than those of European Americans.

20 Jul 2010

NxStage Medical signs 5-year distribution agreement with Spindial

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced that it signed a five-year distribution agreement with Spindial S.p.A., a distributor of renal care products, for the promotion, sale, delivery and service of the NxStage System One™ and certain of the Company's in-center products in Italy.

19 Jul 2010

FCC to step up rural broadband for health care

"The U.S. Federal Communications Commission took the first step Thursday toward reworking a US$400 million-a-year program to subsidize telecommunications services to rural health-care facilities, with the new emphasis on broadband. The commission voted unanimously to approve a notice of proposed rulemaking, or NPRM, designed to bring affordable broadband connectivity to more than 2,000 rural hospitals and clinics across the U.S. The purpose of an NPRM is to ask members of the public whether they agree with the proposed changes" (Gross, 7/15).

17 Jul 2010

New research reports evaluating nephrology market in Europe released

BioTrends Research Group, Inc. has released two new syndicated market research reports evaluating the nephrology market in Europe. The reports, TreatmentTrends: Renal Anemia and TreatmentTrends: Bone and Mineral Metabolism, are derived from the responses of over 200 European nephrologists polled in May and June, 2010 regarding their approach to managing renal anemia and bone and mineral disturbances in their dialysis and chronic kidney disease patients.

16 Jul 2010

High blood pressure, diabetes leads to CKD

People with diabetes and high blood pressure need to take care of their kidneys. According to the July issue of Mayo Clinic Women's HealthSource, chronic kidney disease (CKD) is a growing problem in the United States. The most common causes are diabetes and high blood pressure

16 Jul 2010

Dialysis News and Research

Latest Dialysis News and Research

Study reveals high rate of atrial fibrillation in patients with early stages of CKD

AMAG attributes increased second-quarter revenues of $18.8 million to Feraheme

DaVita releases second annual corporate social responsibility report

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Genzyme accepts CMS decision for delaying Renvela administration to dialysis patients

Medicare to bundle payments for end-stage renal care, reward quality

Fresenius Medical Care, Nikkiso enter 10-year exclusive distribution agreement for dialysis products in Japan

NxStage Medical second-quarter net revenue increases 21% to $44.0 million

African Americans at increased risk of kidney failure caused by hypertension

Discontinuing epoetin can normalize hemoglobin levels in hemodialysis patients

Baxter second-quarter global sales increase 2% to $3.2 billion

World-first dialysis study set to reduce health costs

Cardiac Science issues update on AED recall announced in November 2009

Cardiac Science addresses outstanding issues relating to corrective AED field action with FDA

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

NxStage Medical signs 5-year distribution agreement with Spindial

FCC to step up rural broadband for health care

New research reports evaluating nephrology market in Europe released

High blood pressure, diabetes leads to CKD

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in